Lv1
85 积分 2021-06-21 加入
Comparison of 30-day readmission and same-day discharge rates in patients undergoing pulsed field vs radiofrequency ablation for atrial fibrillation: A multicenter analysis
1天前
已关闭
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
2天前
已完结
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome
6天前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
7天前
已完结
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
9天前
已完结
Catheter ablation of paroxysmal atrial fibrillation and disease progression: Magnitude of the antiprogression effect and role of intervention timing
10天前
已关闭
Effects of nurse-led multidisciplinary team management on cardiovascular hospitalization and quality of life in patients with atrial fibrillation: Randomized controlled trial
10天前
已完结
Age at sampling and sex distribution of AChRAb vs. MuSKAb myasthenia gravis in a large Greek population
14天前
已完结
Outcomes in Relation to the Age at Onset in Patients With Myasthenia Gravis
14天前
已完结
皖公网安备34019202002308
